CD4+ regulatory T cells require CTLA-4 for the maintenance of systemic tolerance

被引:206
作者
Friedline, Randall H. [1 ]
Brown, David S. [1 ]
Nguyen, Hai [1 ]
Kornfeld, Hardy [2 ]
Lee, JinHee [2 ]
Zhang, Yi [3 ]
Appleby, Mark [4 ]
Der, Sandy D. [5 ]
Kang, Joonsoo [1 ]
Chambers, Cynthia A. [1 ]
机构
[1] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01655 USA
[2] Univ Massachusetts, Sch Med, Grad Program Immunol & Virol, Dept Med, Worcester, MA 01655 USA
[3] Amgen Inc, San Francisco, CA 94080 USA
[4] Zymogenet Inc, Seattle, WA 98102 USA
[5] Univ Toronto, Program Prote & Bioinformat, Dept Lab Med & Pathobiol, Toronto, ON M5S 3G4, Canada
基金
美国国家卫生研究院;
关键词
MYELIN BASIC-PROTEIN; TGF-BETA; IN-VIVO; CTLA-4-DEFICIENT MICE; AUTOIMMUNE-DISEASE; IMMUNE-RESPONSES; DENDRITIC CELLS; CUTTING EDGE; ORAL TOLERANCE; ACTIVATION;
D O I
10.1084/jem.20081811
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cytotoxic T lymphocyte antigen-4 (CTLA-4) plays a critical role in negatively regulating T cell responses and has also been implicated in the development and function of natural FOXP3(+) regulatory T cells. CTLA-4-deficient mice develop fatal, early onset lymphoproliferative disease. However, chimeric mice containing both CTLA-4-deficient and -sufficient bone marrow (BM)-derived cells do not develop disease, indicating that CTLA-4 can act in trans to maintain T cell self-tolerance. Using genetically mixed blastocyst and BM chimaeras as well as in vivo T cell transfer systems, we demonstrate that in vivo regulation of Ctla4(-/-) T cells in trans by CTLA-4-sufficient T cells is a reversible process that requires the persistent presence of FOXP3(+) regulatory T cells with a diverse TCR repertoire. Based on gene expression studies, the regulatory T cells do not appear to act directly on T cells, suggesting they may instead modulate the stimulatory activities of antigen-presenting cells. These results demonstrate that CTLA-4 is absolutely required for FOXP3(+) regulatory T cell function in vivo.
引用
收藏
页码:421 / 434
页数:14
相关论文
共 69 条
[11]  
CHEN YH, 1995, J IMMUNOL, V155, P910
[12]   Oral tolerance in myelin basic protein T-cell receptor transgenic mice: Suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells [J].
Chen, YH ;
Inobe, J ;
Kuchroo, VK ;
Baron, JL ;
Janeway, CA ;
Weiner, HL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (01) :388-391
[13]  
Ciubotariu R, 1998, J IMMUNOL, V161, P5193
[14]   The inhibitory cytokine IL-35 contributes to regulatory T-cell function [J].
Collison, Lauren W. ;
Workman, Creg J. ;
Kuo, Timothy T. ;
Boyd, Kelli ;
Wang, Yao ;
Vignali, Kate M. ;
Cross, Richard ;
Sehy, David ;
Blumberg, Richard S. ;
Vignali, Dario A. A. .
NATURE, 2007, 450 (7169) :566-U19
[15]   A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-β- and retinoic acid-dependent mechanism [J].
Coombes, Janine L. ;
Siddiqui, Karima R. R. ;
Arancibia-Carcamo, Carolina V. ;
Hall, Jason ;
Sun, Cheng-Ming ;
Belkaid, Yasmine ;
Powrie, Fiona .
JOURNAL OF EXPERIMENTAL MEDICINE, 2007, 204 (08) :1757-1764
[16]   Modulation of tryptophan catabolism by regulatory T cells [J].
Fallarino, F ;
Grohmann, U ;
Hwang, KW ;
Orabona, C ;
Vacca, C ;
Bianchi, R ;
Belladonna, ML ;
Fioretti, MC ;
Alegre, ML ;
Puccetti, P .
NATURE IMMUNOLOGY, 2003, 4 (12) :1206-1212
[17]   B7-1 engagement of cytotoxic T lymphocyte antigen 4 inhibits T cell activation in the absence of CD28 [J].
Fallarino, F ;
Fields, PE ;
Gajewski, TF .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (01) :205-210
[18]   Immunology of tuberculosis [J].
Flynn, JL ;
Chan, J .
ANNUAL REVIEW OF IMMUNOLOGY, 2001, 19 :93-129
[19]   Abrogation of TGFβ signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease [J].
Gorelik, L ;
Flavell, RA .
IMMUNITY, 2000, 12 (02) :171-181
[20]   Cutting edge: Two distinct mechanisms lead to impaired T cell homeostasis in Janus kinase 3-and CTLA-4-deficient mice [J].
Gozalo-Sanmillan, S ;
McNally, JM ;
Lin, MY ;
Chambers, CA ;
Berg, LJ .
JOURNAL OF IMMUNOLOGY, 2001, 166 (02) :727-730